Health Condition 1: H024- Ptosis of eyelid
Conditions
Interventions
Intervention1: OXYMETAZOLINE 0.1% OPHTHALMIC SOLUTION: OXYMETAZOLINE 0.1% OPHTHALMIC SOLUTION TO BE INSTILLED IN EYE AS ONCE DAILY REGIMEN FOR 42 DAYS
Control Intervention1: NIL: NIL
Sponsors
DR RPCENTRE FOR OPHTHALMIC SCIENCES
Eligibility
Inclusion criteria
Inclusion criteria: 1.PATIENT WITH ACQUIRED PTOSIS 2.PATIENT WITHOUT HISTORY OF PTOSIS CORRECTION 3.PATIENT OR PARENTS WILLING TO GIVE CONSENT
Exclusion criteria
Exclusion criteria: 1.PATIENTS DIAGNOSED AS CONGENITAL PTOSIS 2.PATIENTS WITH HORNER SYNDROME 3.PATIENTS WITH MYASTHENIA GRAVIS 4.PATIENTS HAVING MECHANICAL PTOSIS 5.PATIENTS WITH PSEUDOPTOSIS 6.PATIENTS WITH CEREBRAL OR CORONARY INSUFFICIENCY 7.SJOGREN SYNDROME PATIENTS 8.HYPERTENSIVE PATIENTS 9.GLAUCOMA PATIENTS 10.PATIENTS ON BETA BLOCKERS 11.PATIENTS ON ALPHA ADRENERGIC AGONISTS 12.PATIENTS ON CARDIAC GLYCOSIDES 13.PATIENTS ON MONOAMINE OXIDASE INHIBITORS 14.PATIENTS NOT WILLING TO FOLLOW UP
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.CHANGE FROM BASELINE IN MARGIN TO REFLEX DISTANCE(MRD 1) 2.IMPROVEMENT IN VISUAL FIELDS ON HVF ANALYSIS Timepoint: BASELINE(DAY1), AT 1 WEEK, 6 WEEKS, 7 WEEKS, 8 WEEKS, 3 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.VISION ON SNELLEN VISUAL ACUITY CHART 2.PUPILLARY DIAMETER TO BE MEASURED ON SLIT LAMP 3.CORNEAL FLUORESCEIN STAINING ON SLIT LAMP 4.TEAR FILM STABILITY BY DOING IMPRESSION CYTOLOGYTimepoint: DAY 1 DAY 14 AND DAY 42 | — |
Countries
India
Contacts
Public ContactDR SHRADDHA SNEHA
DR. R.P. CENTRE FOR OPHTHALMIC SCIENCES,ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI
Outcome results
None listed